Complement cascade inhibition in geographic atrophy: a review

por Desai, Dhaval, Dugel, Pravin U.
Publicado 2022

Dexamethasone intravitreal implant in the treatment of diabetic macular edema

por Dugel, Pravin U, Bandello, Francesco, Loewenstein, Anat
Publicado 2015

A case study of choroideremia carrier – Use of multi-spectral imaging in highlighting clinical features

por Dugel, Pravin U., Zimmer, Cheryl N., Shahidi, Ayda M.
Publicado 2016

Evaluation of economic efficiencies in clinical retina practice: activity-based cost analysis and modeling to determine impacts of changes in patient management

por Murray, Timothy G, Tornambe, Paul, Dugel, Pravin, Tong, Kuo Bianchini
Publicado 2011

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)

por Jumper, J Michael, Dugel, Pravin U, Chen, Sanford, Blinder, Kevin J, Walt, John G
Publicado 2018

THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters

por Sadda, SriniVas R., Dugel, Pravin U., Gonzalez, Victor H., Meunier, Esmeralda, Kozma, Petra
Publicado 2019

Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis

por Souied, Eric H., Dugel, Pravin U., Ferreira, Alberto, Hashmonay, Ron, Lu, Jingsong, Kelly, Simon P.
Publicado 2016

Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema

por Kiss, Szilárd, Chandwani, Hitesh S, Cole, Ashley L, Patel, Vaishali D, Lunacsek, Orsolya E, Dugel, Pravin U
Publicado 2016

Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration

por Zakaria, Nadia, Guerard, Nicolas, Emanuelli, Andres, Dugel, Pravin, Watts, Jen, Liew, Melissa, Gekkieva, Margarita, Hinder, Markus
Publicado 2022

Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis

por Kiss, Szilárd, Dugel, Pravin U, Khanani, Arshad M, Broder, Michael S, Chang, Eunice, Sun, Gordon H, Turpcu, Adam
Publicado 2018

PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY

por Mein, Calvin, Dugel, Pravin U., Feiner, Leonard, Drenser, Kim, Miller, Daniel, Benz, Matthew, Meunier, Esmeralda, Moro, Lionel, Fineman, Mitchell S.
Publicado 2020

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

por Dugel, Pravin U, Hillenkamp, Jost, Sivaprasad, Sobha, Vögeler, Jessica, Mousseau, Marie-Catherine, Wenzel, Andreas, Margaron, Philippe, Hashmonay, Ron, Massin, Pascale
Publicado 2016

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)

por Blinder, Kevin J, Dugel, Pravin U, Chen, Sanford, Jumper, J Michael, Walt, John G, Hollander, David A, Scott, Lanita C
Publicado 2017

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema

por Dugel, Pravin U., Khanani, Arshad M., Berger, Brian B., Patel, Sunil, Fineman, Mitchell, Jaffe, Glenn J., Kozma-Wiebe, Petra, Heier, Jeffrey
Publicado 2021

CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA

por Chakravarthy, Usha, Yang, Yit, Lotery, Andrew, Ghanchi, Faruque, Bailey, Clare, Holz, Frank G., Downey, Louise, Weber, Michel, Eter, Nicole, Dugel, Pravin U.
Publicado 2018

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial

por Khanani, Arshad M., Patel, Sunil S., Ferrone, Philip J., Osborne, Aaron, Sahni, Jayashree, Grzeschik, Susanna, Basu, Karen, Ehrlich, Jason S., Haskova, Zdenka, Dugel, Pravin U.
Publicado 2020

Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema

por Khanani, Arshad M., Patel, Sunil S., Gonzalez, Victor H., Moon, Suk J., Jaffe, Glenn J., Wells, John A., Kozma, Petra, Dugel, Pravin U., Maturi, Raj K.
Publicado 2021

Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review stud...

por Dugel, Pravin U., Capone, Antonio, Singer, Michael A., Dreyer, Richard F., Dodwell, David G., Roth, Daniel B., Shi, Rui, Walt, John G., Scott, Lanita C., Hollander, David A.
Publicado 2015

Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: A post hoc analysis of Protocol I data

por Sadda, Srinivas R., Campbell, Joanna, Dugel, Pravin U., Holekamp, Nancy M., Kiss, Szilárd, Loewenstein, Anat, Augustin, Albert J., Shih, Vanessa, Xu, Xiaoshu, Wykoff, Charles C., Whitcup, Scott M.
Publicado 2019

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical Trial

por Sahni, Jayashree, Dugel, Pravin U., Patel, Sunil S., Chittum, Mark E., Berger, Brian, del Valle Rubido, Marta, Sadikhov, Shamil, Szczesny, Piotr, Schwab, Dietmar, Nogoceke, Everson, Weikert, Robert, Fauser, Sascha
Publicado 2020